HPAI journal of virology (original) (raw)
Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice
Gloria Ramirez-Nieto
PLOS ONE, 2008
View PDFchevron_right
A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses
Alice Yu
Proceedings of the National Academy of Sciences, 2008
View PDFchevron_right
Polyvalent DNA Vaccines Expressing HA Antigens of H5N1 Influenza Viruses with an Optimized Leader Sequence Elicit Cross-Protective Antibody Responses
JUN LI
PLoS ONE, 2011
View PDFchevron_right
Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets
Moon-hee Sung
Vaccine, 2009
View PDFchevron_right
Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model
Chairul Anwar Nidom
Vaccine, 2008
View PDFchevron_right
Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses
ami patel
Vaccine, 2009
View PDFchevron_right
DNA vaccines against avian Influenza : Recent Advances and Future Prospects
Sami Khan
View PDFchevron_right
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses
Ted Ross
Vaccine, 2008
View PDFchevron_right
Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
Bin Lu
PLOS Medicine, 2006
View PDFchevron_right
Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine
Stephen Lockhart
PloS one, 2014
View PDFchevron_right
Development of vaccines against influenza H5
I. Gust
The Lancet Infectious Diseases, 2006
View PDFchevron_right
Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development
Justin Bahl
Proceedings of the National Academy of Sciences, 2011
View PDFchevron_right
Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild type H5N1 influenza challenge and control viral loads better than subunit H5N1 vaccine by eliciting high affinity antibodies
swati verma
2012
View PDFchevron_right
Influenza H5 Hemagglutinin DNA Primes the Antibody Response Elicited by the Live Attenuated Influenza A/Vietnam/1203/2004 Vaccine in Ferrets
Shixia Wang
PLoS ONE, 2011
View PDFchevron_right
Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
Ted Ross
PLoS ONE, 2008
View PDFchevron_right
An Inactivated, Adjuvanted Whole Virion Clade 2.2 H5N1 (A/Chicken/Astana/6/05) Influenza Vaccine Is Safe and Immunogenic in a Single Dose in Humans
M. Stukova, B. Khairullin, Maria Sergeeva, Julia Romanova
Clinical and Vaccine Immunology, 2013
View PDFchevron_right
MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
Yasemin Suezer
PLoS ONE, 2009
View PDFchevron_right
Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets
Lucy Breakwell
PloS one, 2015
View PDFchevron_right
Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin
Joel Haynes
Journal of virology, 1997
View PDFchevron_right
Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
Ted Ross
Virology Journal, 2008
View PDFchevron_right
Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models
Eunha Kim
Journal of General Virology, 2014
View PDFchevron_right
Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness
Khristine Kaith Lloren
Vaccine, 2018
View PDFchevron_right
Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunitv in Ferrets
Ted Ross
Journal of Virology, 2011
View PDFchevron_right
A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice
Xian Tang
PloS one, 2013
View PDFchevron_right
Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics
Daniel R Perez
Virology, 2003
View PDFchevron_right
Oligomeric Recombinant H5 HA1 Vaccine Produced in Bacteria Protects Ferrets from Homologous and Heterologous Wild-Type H5N1 Influenza Challenge and Controls Viral Loads Better than Subunit H5N1 Vaccine by Eliciting High-Affinity Antibodies
Ted Ross
Journal of Virology, 2012
View PDFchevron_right
H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans
Ramadevi Raghunandan
Journal of Virology, 2011
View PDFchevron_right
Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets
Ted Ross
Journal of Virology, 2011
View PDFchevron_right
Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret
srinivas rao
PLoS ONE, 2010
View PDFchevron_right
Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
Melanie Saville, Stephanie Pepin, Maria Zambon
Influenza and Other Respiratory Viruses, 2007
View PDFchevron_right